Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 730 clinical trials
  • 0 views
  • 23 May, 2024
  • 1 location
  • 0 views
  • 05 Jun, 2024
  • 1 location
Trial for prescreener data migration( dont use it)  

Trial for prescreener data migration( dont use it)

  • 0 views
  • 15 Jul, 2024
  • 1 location
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)  

This was an open-label, randomized, fed, single-dose, 2-sequence, 2- period crossover study to evaluate the pharmacokinetics and safety between single oral administration of "BR3006" and co-administration of "BR3006A", "BR3006B," and "BR3006C" in healthy adult volunteers.

Accepts healthy volunteers
  • 0 views
  • 05 Nov, 2025
  • 1 location
  • 0 views
  • 14 Mar, 2022
  • 1 location
Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata (APACCO) updated  

Apremilast mediates its clinical effect through the cAMP-PKA-NFkappaB pathway which results in a clinical picture changes to a decrease of all signs of inflammation.Due to the NFkappaB mediated chronical inflammation in the pathogenesis of acne conglobata, a treatment with Apremilast seems to be an effective option.In this study, treatment with …

  • 0 views
  • 14 Mar, 2022
  • 4 locations
  • 0 views
  • 14 Mar, 2022
  • 5 locations
Demo Study  

Demo Study 

Online studies
  • 0 views
  • 25 Apr, 2025
  • 1 location
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI test  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 2 locations
Distal Peripheral Neuropathy in Type 2 Diabetes (DSP/DM)  

Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. This is a preliminary study at assessing the feasibility, efficiency …

  • 0 views
  • 26 Sep, 2022
  • 3 locations